CD44 and breast carcinoma: Moreover, CD44, a matrix glycoprotein and one of the major hyaluronan receptors, serves as an important marker for breast cancer stem cells (CSCs) and has been correlated with resistance against hormonal therapies and enhanced invasive potential in ERα+ breast cancer (Fig. 4) [57].